The pursuit of a healthy life has been a trendy and serious issue for decades.
Undoubtedly, emerging antibiotics will be a lighthouse to guide all mankind towards happiness.
Dr.George has involved in biomedical research field for over a decade, specializing in the research and development of new compounds and new drugs. George has achieved some impressive milestones after graduated from the Department of Plant Pathology, National Chung Hsing University:
2018-Successfully transferred the plant protection Streptomyces Padanus PMS-702 composition and preparation and further improved it into the core extraction technology-ExtrOTM.Established Anti-Microbial Savior BioteQ Co., Ltd. (AMS BioteQ).
2021-AMS BioteQ joined the emerging stock market successfully in Dec.
Director Yeh is graduated from the Institute of Biomedical Engineering, National Taiwan University of Science and Technology, specializing in the development and application of drug carriers and wound dressings. Mainly executing 2019 CITD and 2020 SBIR phase I, respectively.
Dr. Yang Shunxin graduated from the doctoral program of the Department of Pharmacy of Kaohsiung Medical University, majoring in natural product chemistry, and passed the advanced examination for specialized vocational and technical personnel in 2015 to obtain the pharmacist qualification. Her expertise is in the development of new plant drugs, new natural extraction, ingredient identification, and application of natural extracts.
